The current status for metformin use in reproductive medicine

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

Metformin has been used extensively in multiple reproductive settings to ameliorate hyperandrogenism and chronic anovulation, to treat infertility, to prevent miscarriage and to prevent later pregnancy complications as well. Metformin does result in modest improvements in the PCOS phenotype with reductions in circulating insulin and testosterone levels, weight loss, and improved menstrual/ovulatory frequency. It is relatively ineffective as a solo agent to treat infertility, and further has a relative anti-fecundity compared to clomiphene alone. Clomiphene remains the first choice for infertility therapy and the gold standard for women with PCOS. Metformin may be useful in preventing OHSS when used in conjunction with gonadotropins. The use of metformin to prevent pregnancy loss or to prevent pregnancy complications is still experimental and better trials are needed to guide therapy.

Original languageEnglish (US)
Title of host publicationReproductive Endocrinology and Infertility
Subtitle of host publicationIntegrating Modern Clinical and Laboratory Practice
PublisherSpringer New York
Pages183-189
Number of pages7
ISBN (Print)9781441914354
DOIs
Publication statusPublished - Dec 1 2010

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Legro, R. (2010). The current status for metformin use in reproductive medicine. In Reproductive Endocrinology and Infertility: Integrating Modern Clinical and Laboratory Practice (pp. 183-189). Springer New York. https://doi.org/10.1007/978-1-4419-1436-1_12